Menu
← Oncology Approval Tracker
FDA DECISION ·
Lenalidomide (generic Revlimid)
lenalidomide · Natco Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Revlimid in 5, 10, 15 and 25 mg capsules. The FDA list includes multiple myeloma, transfusion-dependent anemia in a specified MDS population, mantle cell lymphoma, and previously treated follicular or marginal zone lymphoma.
LAMPGEN ANALYSIS
Why it matters
The approval opens an ANDA pathway for several established hematologic uses at the listed strengths.
What research teams should watch
Reconcile strength, renal dose adjustments and dispensing under the applicable risk management program.
PRIMARY RECORDS